Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.40274 | 15 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.33521 | 13 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.33902 | 14 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.2844 | 13 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.28312 | 13 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.38536 | 13 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.33504 | 12 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.31883 | 13 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.30298 | 13 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.32687 | 14 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.32361 | 13 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.3092 | 13 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.3523 | 14 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.32669 | 13 |